Adelis Equity

About Adelis Equity

Adelis Equity Partners is a Northern European mid-market private equity firm with €4.25 billion of cumulative capital raised across four funds (Fund IV at €1.6 billion closed in 2025), headquartered in Stockholm. The firm was founded in 2012 as an independent firm launched by partners with backgrounds at Triton and Nordic Capital, and has executed 49 platform investments plus more than 300 add-ons across its track record. Adelis remains a partner-owned independent firm.

Investment thesis

Adelis deploys capital through four flagship funds (Fund I through Fund IV) targeting small-to-mid-cap buyouts and growth investments in Northern Europe, with thematic focus on industry consolidation, digitalisation and international expansion. Sector focus follows a three-vertical thesis spanning business services, tech and software and healthcare and life sciences. Geographic deployment is anchored in Nordics and DACH as primary markets with selective broader Northern European, pan-European and global expansion opportunities. Portfolio companies have delivered average annual growth of approximately 72%, reflecting the platform's buy-and-build playbook applied across the three-vertical investment thesis.

Recent activity

Recent realised exits include business services (Circura, 2026) and healthcare and life sciences (Europa Biosite, 2025). Recent acquisitions include business services (Retta, 2025), tech and software (Aceve), business services (Sakra) and healthcare and life sciences (SSI Diagnostica). The platform continues active deployment of Fund IV across the three-vertical investment thesis. Detailed buyer names and multiple data available on Pro at €29/month.